Cor Vasa 2021, 63(6):675-682 | DOI: 10.33678/cor.2021.109

(Acute pulmonary embolism)

Margita Belicová, Dana Prídavková, Veronika Jankovičová, Miloslav Krajčík, Marian Mokáň
I. interná klinika, Univerzita Komenského v Bratislave, Jesseniova lekárska fakulta v Martine a Univerzitná nemocnica, Martin, Slovensko

Background: Pulmonary embolism is relatively a frequent and dangerous disease with varied manifestations ranging from benign to fatal. The authors in a retrospective study presented a change in the incidence, diagnosis, and treatment of pulmonary embolism during the last 25 years.

Methods: The authors performed a retrospective analysis of 860 (432 men) patients with definitely confirmed pulmonary embolism, who were hospitalized at the Department of Internal Medicine of University Hospital in Martin from January 1996 to December 2020. The source of information about patients were their medical documentations. The authors pointed view on an incidence, risk factors, diagnosis and treatment of pulmonary embolism during presented period.

Results: The patients with confirmed pulmonary embolism created 1.04% of all hospitalized patients with average age 63.9 (SD - 16.98). The average age of men 59.6 (SD - 14.71) was lower compared with women 68.4 (SD - 16.88). Based on the European Society of Cardiology risk stratification, there were pulmonary embolism with high risk in 13.2%, intermediate risk in 40.9% and low risk in 45.9% patients. The source of thrombosis was detected in 42.6% and risk factors for venous thromboembolism in 52.4% of them. 19.5% of all patients with pulmonary embolism were treated with systemic thrombolysis and intracranial bleeding occurred in 1.1% of them. Pulmonary embolism related early mortality rate was 6.9%.

Conclusions: The authors confirmed increasing annual incidence of pulmonary embolism, decreasing annual incidence of massive pulmonary embolism, decreasing pulmonary embolism related mortality rate, but not increasing average age of patients with pulmonary embolism during presented period.

Keywords: Deep vein thrombosis, Predisposing risk factors, Pulmonary embolism, Venous thromboembolism

Received: May 14, 2021; Revised: September 12, 2021; Accepted: September 17, 2021; Published: December 13, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Belicová M, Prídavková D, Jankovičová V, Krajčík M, Mokáň M. (Acute pulmonary embolism). Cor Vasa. 2021;63(6):675-682. doi: 10.33678/cor.2021.109.
Download citation

References

  1. Friedman T, Winokur RS, Quecer KB, Madoff DC. Patient Assessment: Clinical Presentation, Imaging, Diagnosis, Risk Stratification, and the Role of Pulmonary Embolism Response Team. Semin Intervent Radiol 2018;35:116-121. Go to original source... Go to PubMed...
  2. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J 2020;41:543-603. Go to original source... Go to PubMed...
  3. Cohen AT, Agnelli G, Anderson FA, et al. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-764. Go to original source...
  4. Turetz M, Sideris AT, Friedman OA, et al. Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism. Semin Intervent Radiol 2018;35:92-98. Go to original source... Go to PubMed...
  5. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011;171:831-837. Go to original source... Go to PubMed...
  6. Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-2371. Go to original source... Go to PubMed...
  7. Rivera-Lebron B, McDaniel M, Ahrar K, et al. Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Clin Appl Thromb Hemost 2019;25:1076029619853037. Go to original source... Go to PubMed...
  8. Lehnert P, Lange T, Moller CH, et al. Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb Haemost 2018;118:539-546. Go to original source... Go to PubMed...
  9. Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol 2011;86:217-220. Go to original source... Go to PubMed...
  10. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016;118:1340-1347. Go to original source... Go to PubMed...
  11. Barco S, Ende-Verhaar YM, Becattini C, et al. Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2018;39:4186-4195. Go to original source... Go to PubMed...
  12. Prandoni P, Lensing AW, Prins MH, et al. PESIT Investigators. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med 2016;375:1524-1531. Go to original source... Go to PubMed...
  13. Costantino G, Ruwald MH, Quinn J, et al. Prevalence of Pulmonary Embolism in Patients With Syncope. JAMA Intern Med 2018;178:356-362. Go to original source... Go to PubMed...
  14. Konstantinides SV, Barco S, Lankei M, Meyer G. Management of Pulmonary Embolism, An Update. J Am Coll Cardiol 2016;67:976-990. Go to original source... Go to PubMed...
  15. Barco S, Mahmoudpour SH, Planquette B, et al. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systemic review a meta-analysis. Eur Heart J 2019;40:902-910. Go to original source... Go to PubMed...
  16. Ogren M, Bergqvist D, Eriksson H, et al. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J 2005;26:1108-1114. Go to original source... Go to PubMed...
  17. Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. PEITHO Investigators. N Engl J Med 2014;370:1402-1411. Go to original source... Go to PubMed...
  18. Marti C, John G, Konstantinides SV, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015;36:605-614. Go to original source... Go to PubMed...
  19. Konstantinides SV, Vicaut E, Danays T, et al. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol 2017;69:1536-1544. Go to original source... Go to PubMed...
  20. Kucher N, Boekstegers P, Muller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014;129:479-486. Go to original source... Go to PubMed...
  21. Bloomer TL, El-Hayek GE, McDaniel MC, et al. Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis. Catheter Cardiovasc Interv 2017;89:754-760. Go to original source... Go to PubMed...
  22. Yamamoto T. Management of patients with high-risk pulmonary embolism: a narrative review. J Intensive Care 2018;6:16. Go to original source... Go to PubMed...
  23. Keeling WB, Sundt T, Leacche M, et al. Outcomes After Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus: A Multi-Institutional Study. Ann Thorac Surg 2016;102:498-502. Go to original source... Go to PubMed...
  24. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016;149:315-352. Go to original source... Go to PubMed...
  25. Steffel J, Verhamme P, Potpara TS, et al. ESC Scientific Document Group. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018;39:1330-1393. Go to original source... Go to PubMed...
  26. Groetzinger LM, Miller TJ, Rivosecchi RM, et al. Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis. Clin Appl Thromb Hemost 2018;24:908-913. Go to original source... Go to PubMed...
  27. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: The longitudinal investigation of thromboembolism etiology. Am J Med 2004;117:19-24. Go to original source... Go to PubMed...
  28. Rogers MA, Levine DS, Blumberg N, et al. Triggers of hospitalization for venous thromboembolism. Circulation 2012;125:2092-2099. Go to original source... Go to PubMed...
  29. Bell EJ, Folson AR, Lutsey PL, et al. Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis. Diabetes Res Clin Pract 2016;111:10-18. Go to original source... Go to PubMed...
  30. Piazza G, Goldhaber SZ, Kroll A, et al. Venous Thromboembolism in Patients with Diabetes Mellitus. Am J Med 2012;125: 709-716. Go to original source... Go to PubMed...
  31. Karetová D, Bultas J. Koagulopatie provázející teľąí formy koronavirové infekce (COVID-19) - incidence trombotických komplikací, jak jim předcházet a jak je léčit. Cor Vasa 2020;62(Suppl. 1):22-26. Go to original source...
  32. Sakr Y, Giovini M, Leone M, et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review, Ann Intensive Care 2020;10:124. Go to original source... Go to PubMed...
  33. Suh YJ, Hong H, Ohava M, et al.: Pulmonary Embolism and Deep Vein Thrombosis in COVID-19. J Intensive Care. 2018 Mar 2;6:16.
  34. Al-Samkari H. Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19. JAMA 2021;325:1613-1615. Go to original source... Go to PubMed...
  35. INSPIRATION Investigators. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. JAMA 2021;325:1620-1630. Go to original source... Go to PubMed...
  36. Moll M, Zon RL, Sylvester KW, et al. Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score matched analysis. Thromb Res 2021;203:57-60. Go to original source... Go to PubMed...
  37. Kim SY, Jin W, Sood A, et al. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glykoprotein binding interactions. Antiviral Res 2020;181:104873. Go to original source... Go to PubMed...
  38. The ATTACC, ACTIV-4a, and REMAP-CAP Investigators. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med 2021;385:790-802. Go to original source... Go to PubMed...
  39. The ATTACC, ACTIV-4a, and REMAP-CAP Investigators. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med 2021;385:777-789. Go to original source... Go to PubMed...
  40. Khan F, Vaillancourt C, Carrier M. Should we screen extensively for cancer after unprovoked venous thrombosis? BMJ 2017;356:1081. Go to original source... Go to PubMed...
  41. Bohacekova M, Kaldararova M, Valkovicova T, et al. Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification? Bratisl Med J 2016;117:577-582. Go to original source... Go to PubMed...
  42. Lang I, Simonneau G, Pepke-Zaba JW, et al. Factors associated with diagnosis and operabillity of chronic thromboembolic pulmonary hypertension. A case-control study. Thromb Haemostat 2013;110:83-91. Go to original source... Go to PubMed...
  43. Jiménez D, De Miguel-Diez J, Guijarro R, et al. RIETE Investigators. Trenda in the Managements and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry. J Am Coll Cardiol 2016;67:162-170. Go to original source... Go to PubMed...
  44. Root CW, Dudzinski DM, Zakhary B, et al. Multidisciplinary approach to the management of pulmonary embolism patients: the pulmonary embolism response team (PERT). J Multidiscip Healthc 2018;11:187-195. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.